SANDS CAPITAL MANAGEMENT, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Ultragenyx Pharmaceutical Inc. Common Stock, par value $0.001 per share (RARE)

Filing Manager: SANDS CAPITAL MANAGEMENT, LLC
Reporting Manager: SANDS CAPITAL MANAGEMENT, LLC
Security: Ultragenyx Pharmaceutical Inc. Common Stock, par value $0.001 per share
Symbol: RARE
Shares outstanding: 91,446,872 shares
Disclosed Ownership: 4,298,003 shares
Ownership: 4.7%
Form type: SCHEDULE 13G/A
Filing time: 12 Feb 2025, 11:42:47 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
SANDS CAPITAL MANAGEMENT, LLC	4.7%	4,298,003	0	2,965,104	/s/ Alexandra R. Fulk	Alexandra R. Fulk, Chief Compliance Officer, Senior Counsel
SANDS FRANK M.	4.7%	4,298,003	0	2,965,104	/s/ Frank M. Sands	Frank M. Sands